Flossbach Von Storch’s AbbVie ABBV Stock Holding History

Flossbach Von Storch’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-50,500	Closed	-$2.99M	–	92
2015 Q4	$2.99M	Sell	50,500 -45,000	-47%	-$2.59M	0.05%	75
2015 Q3	$5.2M	Hold	95,500	–	–	0.09%	65
2015 Q2	$6.42M	Hold	95,500	–	–	0.12%	60
2015 Q1	$5.59M	Sell	95,500 -26,000	-21%	-$1.57M	0.13%	61
2014 Q4	$7.95M	Sell	121,500 -5,000	-4%	-$315K	0.19%	58
2014 Q3	$7.31M	Hold	126,500	–	–	0.16%	60
2014 Q2	$7.14M	Hold	126,500	–	–	0.17%	55
2014 Q1	$6.5M	Sell	126,500 -66,500	-34%	-$3.36M	0.17%	45
2013 Q4	$10.2M	Sell	193,000 -875,200	-82%	-$43M	0.29%	42
2013 Q3	$47.8M	Buy	1,068,200 +16,800	+2%	+$745K	1.47%	21
2013 Q2	$43.5M	Buy	+1,051,400	New	+$46M	1.31%	24

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Flossbach Von Storch's ABBV Position: Q1 2016 in Review

Flossbach Von Storch sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 50,500 shares — an estimated $2.99M sold.

Flossbach Von Storch first reported a position in ABBV in Q2 2013 and held it in 11 quarters. The position peaked at $47.8M in Q3 2013. 1,640 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Flossbach Von Storch reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
Flossbach Von Storch sold 50,500 AbbVie shares in Q1 2016, an estimated $2.99M.
Flossbach Von Storch first reported a position in AbbVie in Q2 2013 and held it in 11 quarters.
Flossbach Von Storch's AbbVie position peaked at $47.8M in Q3 2013.
1,640 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Flossbach Von Storch's 13F filing for Q1 2016, filed 2 May 2016.